![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Camilleri Michael
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.6, Iss.5, 2005-07, pp. : 491-501
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Genomics and Pharmacogenomics of Brain Disorders
Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The impact of pharmacogenomics on gastrointestinal cancer therapy
By Seufferlein Thomas Boehm Bernhard O
Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. :